Gladstone NOW: The Campaign Join Us on the Journey✕
Bruce Conklin, MD, introduces you to CRISPR, a disruptive technology influencing advances in treatment and cures of diseases through gene editing. Conklin walks you through how CRISPR works before diving into its evolution in his lab at Gladstone, using application examples such as treating cancer, curing Alzheimer’s, and testing drug therapies to prevent cardiac damage in COVID-19 patients. You’ll also hear about this DNA-editing technology’s bright future expanding its reach into cures for more diseases.
Support Our COVID-19 Research Efforts
Gladstone scientists are moving quickly to respond to the coronavirus outbreak. Help us end this pandemic.
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Article
July 1, 2026
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News ReleaseThis Is AI Decoding the Genetic Cause of Disease
Video
March 23, 2026
This Is AI Decoding the Genetic Cause of Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AIScience in Seconds | A New Path Toward Life Without Daily HIV Pills
Video
March 20, 2026
Science in Seconds | A New Path Toward Life Without Daily HIV Pills
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan Lab